The Hindu Business Line : Lupin loses on disappointing Q4 nos

Disappointing fourth quarter results seemed to have forced investors to trim their holdings in Lupin Ltd. The company's shares have come down 20.86 per cent from early this month (Rs 1,275) to Rs 1,009.0 on the BSE. On Wednesday, the shares fell 5.83 per cent from the previous close of Rs 1,094.75. A leading foreign brokerage has put the stock on `underweight' due to "modest growth expectation and rich valuation." The stock is trading at 22 times one-year forward earnings, the brokerage said in a note. The pharmaceutical company, which is active in developing markets with anti-TB and cephalosporin range of products, reported a net profit of Rs 50.2 crore for the fourth quarter, largely on account of other income, the note added.

Rajesh Abraham

More Stories on : Stocks | Ear to the ground

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Kotak MF moots new close-ended fund

Lupin loses on disappointing Q4 nos

Gokaldas survives bear onslaught

Infosys & its crorepatis

Bears prevail

Sensex down 388 points

We will continue to attract FIIs: Chidambaram

Tech indices fare better vis-à-vis benchmarks

Pocket

FIIs continue selling spree

Two CSE brokers suspended

`Foreign fund outflows to persist in near term'

Metal, FMCGs bear the maximum loss

Navayuga plans IPO in second half of fiscal

Evolvence launches $150-m fund